Shockwave therapy shows promise for soothing heel pain

NCT ID NCT07669831

Symptom relief Sponsor: Adly A Adam Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 08, 2026 · Updated 4 times

Summary

This completed study looked at whether extracorporeal shockwave therapy can improve quality of life and reduce pain in people with plantar fasciitis, a common cause of heel pain. Researchers enrolled 175 adults aged 25 to 59 who had heel pain for at least three months. The therapy uses sound waves to stimulate healing at the painful spot on the bottom of the foot.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance: extracorporeal shockwave therapy
What this could lead to: If effective, shockwave therapy could become a standard non-invasive option to ease pain and improve daily function for people with plantar fasciitis.
What could go wrong: This is an observational study, not a randomized trial, so results may be less reliable. The therapy may not work for everyone, and some people may still need other treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

175 people

The number who actually took part.

Started

Apr 2024

Finished

May 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Current observational cohort trial involved participants diagnosed with planter fasciitis, whom age ranged between 25-59 years old, with nearby 3 months of clinical manifestations mainly heel pain. They had plantar medial heel pain: most noticeable with initial steps after a period of inactivity, but also worse following prolonged weight-bearing, * Whom had pain with palpation of the proximal insertion of the plantar fascia. * Whom had positive windlass test.

Ages

25 to 59 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Individuals diagnosed with planter fasciitis, whom age ranged between 25-59 years old, with nearby 3 months of clinical manifestations mainly heel pain. * Whom have plantar medial heel pain: most noticeable with initial steps after a period of inactivity, but also worse following prolonged weight-bearing, * Whom had pain with palpation of the proximal insertion of the plantar fascia. * Whom had positive windlass test. Exclusion Criteria: * Any individual whom underwent feet or ankle surgical interventions, received steroid injections within the past 3 months, also whom have deep venous thrombosis, or had a tarsal tunnel syndrome, diabetic neuropathies or any sort of tumors, lymphatic lesions.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Effectiveness are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

plantar fasciitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Effectiveness Extracoropral shock wave therapy Observational cohort study Planter fasciitis

Shockwave therapy shows promise for soothing heel pain

What the study statuses mean